NEW YORK, January 24, 2022 /PRNewswire/ — The World DNA Sequencing Market should reach $12.55 billion in 2028 and register a revenue CAGR of 11.3% over the forecast period, according to the latest report published by Reports and Data. Key factors driving the revenue growth of the global market include growing demand for personalized medicine, favorable government initiatives, and ongoing drug delivery research.

DNA sequencing is a common technique used to determine the nucleotide sequence of DNA, and it plays a central role in mapping the human genome. Over the years, various sequencing methods such as Sanger sequencing, next generation sequencing and third generation sequencing have been widely used to determine genome sequencing in less time and cost effectively. One of the key factors driving the growth of the global market is the declining cost of genome sequencing and rapid advancements in next-generation sequencing platforms. Furthermore, DNA sequencing is widely used in applications such as biomarker discovery, reproductive health, agrogenomics, forensics, and HLA typing, among others.

The revenue growth of the global market is increasing significantly owing to the increasing cancer research and cancer treatment, rising demand for simple and rapid clinical diagnostics, and availability of public and private sector funds. Moreover, various market players are investing heavily in the development of improved and cost-effective consumables and portable sequencing technologies. This gives a major boost to the global market. However, factors such as high initial investments, expensive reagents and kits, and shortage of skilled professionals to operate advanced equipment and interpret genomic data are expected to hamper the overall market growth to some extent during the forecast period.

Request a sample report

Some key highlights of the report:

  • Among DNA sequencing technologies, the third generation sequencing segment is expected to register a rapid revenue CAGR during the forecast period owing to the increasing adoption of real-time nanopore and single molecule sequencing owing to easy and fast gene amplification and their ability to produce longer reads. than second-generation sequencing.
  • Based on the end use, the academic research segment is expected to account for a major share of revenue during the forecast period. This can be attributed to rising healthcare spending, growing number of research and academic institutes, increased funding for research and drug discovery, and increased collaborations between major companies. and research institutes.
  • North America is expected to account for the largest revenue share in the global market over the forecast period due to rising incidence of cancer, increase in research and development activities, presence of healthcare facilities well-developed research facilities, the availability of well-trained laboratory technicians, and the growing demand for personalized medicine. Additionally, increasing investments in drug discovery and availability of advanced consumables and equipment are expected to fuel the growth of the North American market.

Request a personalized research report @

  • the Asia Pacific The market is expected to register the fastest revenue CAGR over the forecast period owing to rising prevalence of chronic diseases, improved healthcare infrastructure and research facilities, increasing adoption of advanced sequencing, growing demand for genetic testing and growing investment to develop improved, cost-effective products. some products.
  • 23andMe, Oxford Nanopore Technologies Ltd.,, 54Gene, Guardant Health, Allogene Therapeutics, Pacific Biosciences, CardioDx, Helix, Human Longevity, Foundation Medicine, Freenome, Veritas Genetics, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc. , Illumina, Inc., Pacific Biosciences California, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Macrogen, Inc., Perkin Elmer, Inc., BGI, Bio-Rad Laboratories, Inc., Myriad Genetics, PierianDx, Eurofins Scientific and Intrexon Bioinformatics Germany GmbH are certain key companies operating in the global DNA sequencing market.

To identify key industry trends, a research study at

For this report, Reports and Data has segmented the global DNA sequencing market based on products and services, technology, application, end-use, and region:

Product and service outlook (Revenue, billion USD, 2018-2028)

  • Consumables
  • Instruments
  • Services

Technology outlook (Revenue, billion USD, 2018-2028)

  • Sanger sequencing
  • Next Generation Sequencing
    • Whole Genome Sequencing (WGS)
    • Whole exome sequencing (WES)
    • Targeted sequencing and resequencing
  • Third Generation DNA Sequencing
    • Single Molecule Real-Time Sequencing (SMRT)
    • Nanopore sequencing

Application Outlook (Revenue, billion USD, 2018-2028)

  • Oncology
  • reproductive health
  • Clinical investigation
  • Agrigenomics and forensics
  • HLA typing/Immune system monitoring
  • Metagenomics, epidemiology and drug development
  • Consumer Genomics
  • Others

End-use prospects (Revenue, billion USD, 2018-2028)

  • Academic research
  • Clinical research
  • Hospitals & Clinics
  • Pharmaceutical and biotechnology companies
  • Others

Buy Premium Research Report @

Regional Outlook (Revenue, USD Billion, 2018-2028)

  • North America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Benelux
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
  • Middle East & Africa
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Israel
    • Rest of MEA

Explore trending research reports by reports and data:

Pulmonary In Vitro Market the size was $273.7 million in 2020 and is expected to record a robust CAGR of 17.9% over the forecast period. Rising prevalence of lung infections such as COPD, asthma, and lung cancer, and increasing investment in drug development procedures are key factors driving the revenue growth of the global market

clinical microbiology market the size was $4.1 billion in 2020 and is expected to register a CAGR of 6.7% during the forecast period. Rising prevalence of infectious diseases globally, growing need for early detection of pathogen-borne diseases, and technological advancements in disease diagnosis are key factors responsible for the growth of the global clinical microbiology market.

capillary blood collection market the size was $1.40 billion in 2020 and is expected to register a CAGR of 5.3% over the forecast period. Rising prevalence of various diseases across the globe and growing need for minimally invasive methods are some of the major factors fueling the revenue growth of the global capillary blood collection market.

Nuclear Imaging Equipment Market the size was $2.5 billion in 2020 and is expected to register a CAGR of 4.6% over the forecast period. The major drivers of market revenue growth are the growing focus on personalized drugs and advancements in radiotracers.

Metal can market The size was significantly robust in 2020 and is expected to register a steady revenue CAGR over the forecast period. The high recyclability of metal cans is one of the main market drivers. Making products from recycled metals requires less energy and reduces carbon emissions. It also uses less water compared to using raw materials.

About reports and data

Reports and Data is a market research and consulting firm that provides syndicated research reports, custom research reports and consulting services. Our solutions are uniquely focused on your goal of locating, targeting and analyzing changes in consumer behavior across demographics, across industries, and helping customers make smarter business decisions. We offer market intelligence research ensuring relevant and factual research across multiple sectors including healthcare, touchpoints, chemicals, commodities and energy. We are constantly updating our search offerings to ensure that our clients are aware of the latest trends existing in the market. Reports and Data has a strong base of experienced analysts in various areas of expertise. Our industry experience and ability to develop a workable solution to any research problem gives our clients the ability to secure an edge over their respective competitors.

Jean W
Business Development Manager
Reports and data | The Web:
Direct line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs
Read the latest press release @

SOURCE reports and data